Abstract
Abnormal aggregation of TAR DNA-binding protein 43 (TDP-43) is a pathological hallmark of motor neuron disease (MND), yet current methods for quantifying these aggregates in biological samples remain limited in sensitivity and resolution. Here, single-molecule fluorescence microscopy is applied to post-mortem brain extracts to quantitatively characterize aggregates containing TDP-43 at the individual particle level. The resulting aggregate fingerprints, consisting of morphological and compositional profiles, are sufficient to distinguish MND donors from neurologically normal controls and further discriminate between clinically distinct MND subgroups. Comparative proteomic analysis confirms and extends these findings, revealing convergent and complementary molecular signatures. These results demonstrate, for the first time, that single-molecule aggregate profiling can stratify MND cases using patient-derived tissues, paving the way for the development of sensitive minimally invasive diagnostics and mechanistically informed disease monitoring tools.
| Original language | English |
|---|---|
| Article number | e05484 |
| Number of pages | 13 |
| Journal | Advanced Science |
| Volume | 12 |
| Issue number | 44 |
| Early online date | 23 Sept 2025 |
| DOIs | |
| Publication status | Published - 27 Nov 2025 |
Bibliographical note
The authors were grateful to all donors, their family members and caregivers, for making this study possible. We acknowledge the MRC London Neurodegenerative Diseases Brain Bank and the Brains for Dementia Research project specifically Dr Claire Troakes, for facilitating the collection, storage and provisioning of donated tissues.Data Availability Statement
The data that support the findings of this study are openly available in PRIDE at https://www.ebi.ac.uk/pride/, reference number 61429.Funding
This work was supported by the UK Dementia Research Institute, which receives its funding from DRI Ltd., funded by the UK Medical Research Council, Alzheimer's Society, and Alzheimer's Research. We would also like to acknowledge the support of the UK Dementia Research Institute Proteomics Platform, led by Dr Bethany Geary, and technical support in the form of reagents provided by Dr Yu P. Zhang (University of Cambridge). D.C. was supported by the Lady Edith Wolfson Junior Non-Clinical Research Fellowship awarded by the MND Association UK (Cox 971-799). JS was supported by a Wellcome Trust Senior Research Fellowship (221824/Z/20/Z). JMG was supported by a Motor Neurone Disease Association grant (Gregory/APR24/2374-791), and both JMG and FMW were supported by a Target ALS grant (BB-2022-C4-L2). MAW was supported by an Alzheimer's Research UK Research Fellowship (ARUK-RF2020A-008), an award from The Sean M. Healey & AMG Center for ALS at Mass General and ALS FindingACure, and the Rosetrees Trust (CF2/100004). EL was supported by a grant from Parkinson's UK (G-1901).
| Funders | Funder number |
|---|---|
| Alzheimer's Research UK | ARUK‐RF2020A‐008 |
| Wellcome Trust | 221824/Z/20/Z |
| Motor Neurone Disease Association | Gregory/APR24/2374‐791, BB‐2022‐C4‐L2, 971‐799 |
| CF2/100004 | |
| Parkinson's UK | G‐1901 |
Keywords
- motor neuron disease
- protein aggregates
- proteomics
- single-molecule microscopy